SpineThera Featured as a Minnesota Company Working On Alternatives for Opioid Pain Medication

Read More
October 4, 2017

SpineThera Featured as a Minnesota Company Working On Alternatives for Opioid Pain Medication

SpineThera was featured in three news stories published by the Star Tribune about Minnesota companies working on non-opioid technologies to reduce pain. The direct links to the stories can be found below:

Minnesota medical companies work on alternatives for opioid drugs

Minnesota-made anti-pain therapies

State lawmakers gather new ideas for pain treatment from Minnesota Companies

Previous Article
Next Article
SPINETHERA Awarded $5 Million
Grant From Department of Defence
June 17, 2024

SpineThera, Inc. to collaborate with Mayo Clinic to advance solutions in substance abuse disorder treatment

SpineThera, Inc. to collaborate with Mayo Clinic to advance solutions in substance abuse disorder treatment
Read More
April 3, 2024

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property
Read More
October 5, 2023

SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office

PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for transforaminal epidural injection [TF-EI] for the management of sciatica pain) today announced United States Patent and Trademark Office (USPTO) has issued Patent No. 11,771,707 related to its micro-suspension platform technology.
Read More

Proven health impact

SpineThera produce more effective health-benefit leads, with a higher hit rate, in less time than any other method available today.
Contact Us
Platform Technology Supported by R&D and cGMP Capabilities
SpineThera, Inc. 15600 Medina Road Suite 247, Plymouth, MN 55447